Filling the Gaps in the Screening Marketplace
Our team of experts and doctors saw the need in the marketplace for noninvasive, contactless screening, and with our Safe Entry Stations, we have done just that. Our new AI products in development will give medical professionals tools that empower their decision-making for better patient outcomes.
Recent Developments
Recent Press
Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening
Toronto, Ontario – March 20, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that the US Patent Office has granted a patent for its AI-powered technology (United States Patent Application Number: 16/892,369) for […]
Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis
Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcohol Predictmedix’s screening to identify impairment takes less than 30 seconds The mobile application, powered by AI algorithms currently being utilized in Safe Entry will be accompanied by a “mini” multi-spectral imaging camera resulting in a portable non-invasive impairment detection […]
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry’s Medical Device Regulatory Approval in Indonesia
The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix’s Safe Entry for regulatory approval listed as a ‘Medical Device’ Medical device classification allows Predictmedix to commercialize Safe Entry at scale in Indonesia Third-party clinical validation yet another milestone for Predictmedix’s AI-Powered screening technology Toronto, Ontario, March 8, 2023 – […]